- Home
- Diabetes Care
- Diabetes Type 2
- Semaglutide 0.25 mg FlexTouch Pen


Semaglutide 0.25 mg FlexTouch Pen
| Active Ingredient | Semaglutide |
|---|---|
| Indication: | weight loss and maintenance for overweight or obese adults |
| Manufacturer: | Novo Nordisk India |
| Packaging: | 1 Pen & 4 Disposable Needles |
| Strength: | 0.25mg |
| Delivery Time: | 6 To 15 days |
Write a review

Semaglutide 0.25 mg FlexTouch Pen | ||||
|---|---|---|---|---|
| 0.25mg | Price | Price/unit | Qty | Cart |
| 1 Pen | $440.00 | $440.00 / Pen | ||
| 2 Pen/s | $820.00 | $410.00 / Pen | ||
| 3 Pen/s | $1,200.00 | $400.00 / Pen | ||
Alternative Medicine
View MoreWhat is Semaglutide 0.25 mg FlexTouch Pen?
Semaglutide 0.25 mg FlexTouch Pen is a prescription medication designed primarily to support weight loss and maintenance in adults who are overweight or obese. Manufactured by Novo Nordisk India, this injectable pen provides a convenient, accurate, and user-friendly way to deliver the active ingredient Semaglutide. It belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists which have been clinically proven to assist in weight management programs when combined with diet and exercise.
This product is specifically formulated to deliver a low starting dose of 0.25 mg, which helps patients adjust to treatment and minimizes side effects during the initial phase. The FlexTouch Pen device allows for simple once-weekly self-administration, making it easier for patients to incorporate the treatment into their daily routines. The pen features an ergonomic design and a hidden needle to enhance comfort and reduce injection anxiety.
Used under medical supervision, Semaglutide 0.25 mg FlexTouch Pen supports effective weight reduction by regulating appetite and improving blood sugar control, without making unrealistic health claims. It is an important advancement in the pharmaceutical approach toward obesity and related metabolic conditions.
Uses of Semaglutide 0.25 mg FlexTouch Pen
- Weight loss for overweight or obese adults
- Weight maintenance following initial weight reduction
- Support for lifestyle changes including diet and physical activity
- Potential improvement in blood glucose levels in patients with metabolic issues
How Semaglutide 0.25 mg FlexTouch Pen Works
Semaglutide mimics the action of the naturally occurring hormone GLP-1 in the body. It works by binding to GLP-1 receptors, which helps regulate appetite and food intake. This results in feelings of fullness or satiety, leading to reduced calorie consumption. Additionally, Semaglutide slows gastric emptying, which contributes to prolonged satiety and better blood sugar control.
By enhancing insulin secretion and decreasing glucagon secretion in a glucose-dependent manner, Semaglutide plays a critical role in reducing body weight and improving metabolic health. It supports the body’s natural processes without forcing unrealistic weight changes.
How to take Semaglutide 0.25 mg FlexTouch Pen
Semaglutide 0.25 mg FlexTouch Pen is intended for once-weekly subcutaneous injection. Patients should be instructed by their healthcare provider on proper injection techniques. The injection site can be in the abdomen, thigh, or upper arm, and sites should be rotated each week to avoid irritation.
The pen’s dose should be taken consistently on the same day each week. It does not require dose adjustment based on meals, but adherence to a balanced diet and physical activity is essential for optimal results. Do not share the pen with others and always follow disposal instructions for used needles.
Benefits of Semaglutide 0.25 mg FlexTouch Pen
- Effective reduction in body weight in overweight or obese adults
- Improves feelings of fullness and reduces appetite
- Simple, once-weekly dosing enhances compliance
- Ergonomic pen design with hidden needle for comfortable injections
- Supports lifestyle modifications for long-term weight management
- Manufactured by trusted pharmaceutical company Novo Nordisk India
Dosage and Administration
The usual starting dose of Semaglutide is 0.25 mg once weekly to minimize gastrointestinal side effects. After 4 weeks, the dose is typically increased as directed by the healthcare provider to reach an effective maintenance dosage.
Administer by subcutaneous injection at the recommended injection sites. Follow your healthcare provider's instructions carefully regarding dose escalation and treatment duration.
Who Should Use Semaglutide 0.25 mg FlexTouch Pen?
Semaglutide 0.25 mg FlexTouch Pen is suitable for overweight or obese adults with a body mass index (BMI) that places them at increased risk of health complications. It is intended for those who have not achieved adequate weight loss through diet and exercise alone and require pharmacological support as part of a comprehensive weight management plan.
Who Should Avoid Semaglutide 0.25 mg FlexTouch Pen?
Use is contraindicated in individuals with known hypersensitivity to Semaglutide or any components of the pen. It is not recommended for patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
It should be avoided in patients with severe gastrointestinal diseases or histories of pancreatitis unless under close medical supervision. Pregnant or breastfeeding women should not use Semaglutide.
Side Effects of Semaglutide 0.25 mg FlexTouch Pen
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Abdominal pain
- Headache
- Dizziness
- Injection site reactions such as redness or swelling
- Fatigue
- Indigestion
Safety Advice
- Consult a healthcare provider before starting treatment
- Inform your doctor about any other medications or health conditions
- Report any severe or persistent side effects immediately
- Do not exceed the prescribed dose
- Follow storage guidelines carefully to maintain medication efficacy
- Pregnant or breastfeeding women should avoid this medication
- Keep out of reach of children
Drug Interactions
- May affect the effectiveness of other antidiabetic medications
- Use caution with drugs that delay gastric emptying
- Potential interactions with insulin or sulfonylureas increasing hypoglycemia risk
- Consult a healthcare provider for a full list of possible interactions
Storage Instructions
Store the Semaglutide 0.25 mg FlexTouch Pen in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze the product. Keep the pen in the original carton to protect it from light. Do not use the pen beyond the expiry date, and once in use, keep it at room temperature and use within 6 weeks.
Where to buy Semaglutide 0.25 mg FlexTouch Pen in Malaysia?
Semaglutide 0.25 mg FlexTouch Pen is available in Malaysia through licensed pharmacies and authorized online medical suppliers. It is essential to purchase from reputable sources to ensure the authenticity and quality of the medication. Consulting a healthcare provider for a prescription and guidance on the correct purchase channels is highly recommended.
Frequently Asked Questions (FAQ)
What is the price of Semaglutide 0.25 mg FlexTouch Pen in Malaysia?
The price may vary depending on the pharmacy or online retailer, but it is generally affordable when purchased through authorized channels. Contact local pharmacies or consult your healthcare provider for current pricing details.
What happens if I miss a dose?
If a dose is missed, take it as soon as you remember within 5 days of the missed dose. If more than 5 days have passed, skip the missed dose and continue with your next scheduled weekly injection.
Where can I find Semaglutide 0.25 mg FlexTouch Pen for sale?
It can be purchased at licensed pharmacies in Malaysia or through verified online drugstores. Ensure you have a valid prescription before purchasing.
Is Semaglutide 0.25 mg FlexTouch Pen available in Malaysia?
Yes, this medication is available in Malaysia and can be obtained legally with proper medical authorization.
Can I store the Semaglutide pen at room temperature?
Once opened, it can be stored at room temperature for up to 6 weeks but should be kept away from direct heat and light.
Is Semaglutide 0.25 mg FlexTouch Pen suitable for all adults?
It is intended for adults who are overweight or obese and under medical supervision. It is not recommended for everyone; consult your healthcare provider for eligibility.
Can Semaglutide be used with other weight loss medications?
Combining Semaglutide with other weight loss drugs should only be done under strict medical guidance to avoid adverse effects.
Conclusion
Semaglutide 0.25 mg FlexTouch Pen offers a clinically supported, convenient, and effective option for adults seeking to manage their weight safely and sustainably. Manufactured by Novo Nordisk India, this once-weekly pen device combines the benefits of pharmacological therapy with ease of use, helping to promote appetite control and weight loss when paired with healthy lifestyle changes. Ensure usage under professional healthcare guidance to maximize benefits and minimize risks. Semaglutide represents a significant advancement in the management of overweight and obesity, supporting patients on their journey toward improved health outcomes.
No reviews yet.
Semaglutide 0.25 mg FlexTouch Pen Is Out Of Stock
Sorry! Semaglutide 0.25 mg FlexTouch Pen Is Out Of Stock.
Please click below to view other similar medications.

Semanext Injection (Semaglutide)
View Treatment


Leave A Review